Does DOBUTAMINE Cause Benign prostatic hyperplasia? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Benign prostatic hyperplasia have been filed in association with DOBUTAMINE (Dobutamine). This represents 1.5% of all adverse event reports for DOBUTAMINE.
24
Reports of Benign prostatic hyperplasia with DOBUTAMINE
1.5%
of all DOBUTAMINE reports
24
Deaths
23
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From DOBUTAMINE?
Of the 24 reports, 24 (100.0%) resulted in death, 23 (95.8%) required hospitalization, and 23 (95.8%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOBUTAMINE. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does DOBUTAMINE Cause?
Drug ineffective (556)
Off label use (325)
Cardiogenic shock (316)
Multiple organ dysfunction syndrome (297)
Condition aggravated (272)
Sepsis (264)
Abdominal distension (259)
General physical health deterioration (258)
Hyponatraemia (256)
Appendicitis (252)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which DOBUTAMINE Alternatives Have Lower Benign prostatic hyperplasia Risk?
DOBUTAMINE vs DOBUTAMINE\DOBUTAMINE
DOBUTAMINE vs DOCETAXEL
DOBUTAMINE vs DOCETAXEL ANHYDROUS
DOBUTAMINE vs DOCETAXEL\DOCETAXEL ANHYDROUS
DOBUTAMINE vs DOCONEXENT